Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the women's interagency HIV study

Joseph G. Feldman, Howard Minkoff, Michael F. Schneider, Stephen J. Gange, Mardge Cohen, D. Heather Watts, Monica Gandhi, Robert S. Mocharnuk, Kathryn Anastos

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

Objective. We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women. Methods. Data were analyzed from the Women's Interagency HIV Study, a multisite longitudinal study up to 7.9 years for 924 women representing 72% of all women who initiated HAART between July 1, 1995, and September 30, 2003. Results. When Cox's regression was used after control for age, race, hepatitis C infection, illicit drug use, previous antiretroviral therapy, and previous AIDS, smokers on HAART had poorer viral responses (hazard ratio [HR] = 0.79; 95% confidence interval [CI] = 0.67, 0.93) and poorer immunologic response (HR = 0.85; 95% CI = 0.73, 0.99). A greater risk of virologic rebound (HR = 1.39; 95% CI = 1.06, 1.69) and more frequent immunologic failure (HR = 1.52; 95% CI = 1.18, 1.96) were also observed among smokers. There was a higher risk of death (HR = 1.53; 95% CI = 1.08, 2.19) and a higher risk of developing AIDS (HR = 1.36; 95% CI = 1.07, 1.72) but no significant difference between smokers and nonsmokers in the risk of death due to AIDS. Conclusions. Some of the benefits provided by HAART are negated in cigarette smokers.

Original languageEnglish (US)
Pages (from-to)1060-1065
Number of pages6
JournalAmerican Journal of Public Health
Volume96
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Highly Active Antiretroviral Therapy
Smoking
HIV
Confidence Intervals
Acquired Immunodeficiency Syndrome
Street Drugs
Hepatitis C
Tobacco Products
Longitudinal Studies
Infection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Association of cigarette smoking with HIV prognosis among women in the HAART era : A report from the women's interagency HIV study. / Feldman, Joseph G.; Minkoff, Howard; Schneider, Michael F.; Gange, Stephen J.; Cohen, Mardge; Watts, D. Heather; Gandhi, Monica; Mocharnuk, Robert S.; Anastos, Kathryn.

In: American Journal of Public Health, Vol. 96, No. 6, 06.2006, p. 1060-1065.

Research output: Contribution to journalArticle

Feldman, Joseph G. ; Minkoff, Howard ; Schneider, Michael F. ; Gange, Stephen J. ; Cohen, Mardge ; Watts, D. Heather ; Gandhi, Monica ; Mocharnuk, Robert S. ; Anastos, Kathryn. / Association of cigarette smoking with HIV prognosis among women in the HAART era : A report from the women's interagency HIV study. In: American Journal of Public Health. 2006 ; Vol. 96, No. 6. pp. 1060-1065.
@article{53b5712b75a6473b97c7fda9a62fb44b,
title = "Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the women's interagency HIV study",
abstract = "Objective. We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women. Methods. Data were analyzed from the Women's Interagency HIV Study, a multisite longitudinal study up to 7.9 years for 924 women representing 72{\%} of all women who initiated HAART between July 1, 1995, and September 30, 2003. Results. When Cox's regression was used after control for age, race, hepatitis C infection, illicit drug use, previous antiretroviral therapy, and previous AIDS, smokers on HAART had poorer viral responses (hazard ratio [HR] = 0.79; 95{\%} confidence interval [CI] = 0.67, 0.93) and poorer immunologic response (HR = 0.85; 95{\%} CI = 0.73, 0.99). A greater risk of virologic rebound (HR = 1.39; 95{\%} CI = 1.06, 1.69) and more frequent immunologic failure (HR = 1.52; 95{\%} CI = 1.18, 1.96) were also observed among smokers. There was a higher risk of death (HR = 1.53; 95{\%} CI = 1.08, 2.19) and a higher risk of developing AIDS (HR = 1.36; 95{\%} CI = 1.07, 1.72) but no significant difference between smokers and nonsmokers in the risk of death due to AIDS. Conclusions. Some of the benefits provided by HAART are negated in cigarette smokers.",
author = "Feldman, {Joseph G.} and Howard Minkoff and Schneider, {Michael F.} and Gange, {Stephen J.} and Mardge Cohen and Watts, {D. Heather} and Monica Gandhi and Mocharnuk, {Robert S.} and Kathryn Anastos",
year = "2006",
month = "6",
doi = "10.2105/AJPH.2005.062745",
language = "English (US)",
volume = "96",
pages = "1060--1065",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "6",

}

TY - JOUR

T1 - Association of cigarette smoking with HIV prognosis among women in the HAART era

T2 - A report from the women's interagency HIV study

AU - Feldman, Joseph G.

AU - Minkoff, Howard

AU - Schneider, Michael F.

AU - Gange, Stephen J.

AU - Cohen, Mardge

AU - Watts, D. Heather

AU - Gandhi, Monica

AU - Mocharnuk, Robert S.

AU - Anastos, Kathryn

PY - 2006/6

Y1 - 2006/6

N2 - Objective. We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women. Methods. Data were analyzed from the Women's Interagency HIV Study, a multisite longitudinal study up to 7.9 years for 924 women representing 72% of all women who initiated HAART between July 1, 1995, and September 30, 2003. Results. When Cox's regression was used after control for age, race, hepatitis C infection, illicit drug use, previous antiretroviral therapy, and previous AIDS, smokers on HAART had poorer viral responses (hazard ratio [HR] = 0.79; 95% confidence interval [CI] = 0.67, 0.93) and poorer immunologic response (HR = 0.85; 95% CI = 0.73, 0.99). A greater risk of virologic rebound (HR = 1.39; 95% CI = 1.06, 1.69) and more frequent immunologic failure (HR = 1.52; 95% CI = 1.18, 1.96) were also observed among smokers. There was a higher risk of death (HR = 1.53; 95% CI = 1.08, 2.19) and a higher risk of developing AIDS (HR = 1.36; 95% CI = 1.07, 1.72) but no significant difference between smokers and nonsmokers in the risk of death due to AIDS. Conclusions. Some of the benefits provided by HAART are negated in cigarette smokers.

AB - Objective. We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women. Methods. Data were analyzed from the Women's Interagency HIV Study, a multisite longitudinal study up to 7.9 years for 924 women representing 72% of all women who initiated HAART between July 1, 1995, and September 30, 2003. Results. When Cox's regression was used after control for age, race, hepatitis C infection, illicit drug use, previous antiretroviral therapy, and previous AIDS, smokers on HAART had poorer viral responses (hazard ratio [HR] = 0.79; 95% confidence interval [CI] = 0.67, 0.93) and poorer immunologic response (HR = 0.85; 95% CI = 0.73, 0.99). A greater risk of virologic rebound (HR = 1.39; 95% CI = 1.06, 1.69) and more frequent immunologic failure (HR = 1.52; 95% CI = 1.18, 1.96) were also observed among smokers. There was a higher risk of death (HR = 1.53; 95% CI = 1.08, 2.19) and a higher risk of developing AIDS (HR = 1.36; 95% CI = 1.07, 1.72) but no significant difference between smokers and nonsmokers in the risk of death due to AIDS. Conclusions. Some of the benefits provided by HAART are negated in cigarette smokers.

UR - http://www.scopus.com/inward/record.url?scp=33744779438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744779438&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2005.062745

DO - 10.2105/AJPH.2005.062745

M3 - Article

C2 - 16670229

AN - SCOPUS:33744779438

VL - 96

SP - 1060

EP - 1065

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 6

ER -